Assessment of a Semi-Solid Extrusion Based Compounding System Solution for Personalized Ondansetron Dosage Forms Combined with Raman Spectroscopy Analysis

Bahman, J. Zini, J. Lahtinen, N. Hassinen, S. Verma, T. Laaksonen, S. Airaksinen, N. Sandler Topelius, T. Viitala

[ Pharm. Res. 2025, ; https://doi.org/10.1007/s11095-025-03911-6 ]

An automated SSE based Compounding System Solution (CSS) technology was assessed for creating customized Ondansetron tablets. Additionally, a non-destructive quality control method for the customized Ondansetron tablets was developed by utilizing Raman Spectroscopy (RS) measurements and partial least square (PLS) analysis. The mass uniformity tests showed high accuracy: 99.2% for varying drug content and 98.8% for different tablet sizes. All tablets met the acceptance criteria (AV < 15) and remained stable for six months at 25 ± 2 °C and ambient humidity. In-vitro dissolution tests confirmed over 85% drug release within 30 min, complying with USP standards. The RS-based PLS model predicted active pharmaceutical ingredient (API) content with a slope of 0.944 and an error of ~ 8%, which improved to 2-3% when excluding highly variable 10 mg samples. The model showed strong correlation with HPLC results and prediction (R2CV = 0.95, RMSECV = 0.68; R2Pred = 0.96, RMSEP = 0.57), using three latent variables.

Author: pssrc_admin